| BCBS New Mexico Medical Policies | Tocilizumab and Associated Biosimilar(s) | 2026-04-01 |
| BCBS New Mexico Medical Policies | Triamcinolone acetonide | 2026-04-01 |
| BCBS New Mexico Medical Policies | Unicondylar Interpositional Spacer as a Treatment of | 2026-04-01 |
| BCBS New Mexico Medical Policies | Vedolizumab | 2026-04-01 |
| Medicare NCD | NCD 110.17 - Anti-Cancer Chemotherapy for Colorectal Cancer - RETIRED | 2026-04-01 |
| Ambetter Health Michigan Meridian Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| Ambetter Health Mississippi Magnolia Clinical | Skin and Soft Tissue Substitutes | 2026-04-01 |
| BCBS Highmark Penn Medicare Advantage | Percutaneous Coronary Intervention | 2026-04-01 |
| BCBS Highmark Penn Medicare Advantage | Panretinal (Scatter) Laser Photocoagulation | 2026-04-01 |
| HealthPartners | Teprotumumab-trbw (Tepezza®) and veligrotug-vvze | 2026-04-01 |